Peptide Fox
CalculatorPeptide LibraryContent Lab
  1. Home
  2. Content
  3. Glow Protocol Complete Guide

    Protocol Guide

    GLOW Protocol: Complete Guide to Coordinated Tissue Regeneration

    The GLOW protocol represents a breakthrough in peptide therapy: a single-vial formulation combining three peptides (GHK-Cu, BPC-157, and TB-4) in optimized ratios for coordinate…

    The GLOW protocol represents a breakthrough in peptide therapy: a single-vial formulation combining three peptides (GHK-Cu, BPC-157, and TB-4) in optimized ratios for coordinated tissue regeneration. Unlike random peptide combinations, GLOW delivers simultaneous signals that address different bottlenecks in the healing process—creating organized, high-quality tissue repair instead of chaotic scarring.

    This guide covers everything you need to know: the science behind coordinated cascade healing, complete dosing protocols, timeline expectations, and practical implementation.


    Table of Contents

    1. Quick Reference
    2. GLOW Vial Composition - Understanding Each Component
    3. Why Coordination Matters - All Three Peptides Work Simultaneously - The Synergy Effect - Why the 50/10/10 Ratio
    4. Complete GLOW Protocol Benefits - Primary Benefits - Secondary Benefits - Long-Term Benefits - Timeline: Week-by-Week Progression
    5. Complete Dosing Protocol - Phase 1: Activation (Weeks 1-4) - Phase 2: Remodeling (Weeks 5-8) - Phase 3: Maintenance (Weeks 9+) - Administration & Reconstitution
    6. Safety & Contraindications
    7. Cost Analysis
    8. Frequently Asked Questions

    Glow at a Glance

    Quick Reference

    Vial Contents50mg GHK-Cu, 10mg BPC-157, 10mg TB-4 (lyophilized powder)
    ReconstitutionAdd 5mL bacteriostatic water (creates 10mg/mL GHK-Cu, 2mg/mL BPC-157, 2mg/mL TB-4)
    Dosing0.25mL per injection (frequency varies by phase)
    Duration8-12 weeks standard protocol
    Vials Needed2-3 vials for 12-week protocol (each vial provides 20 doses @ 0.25mL)
    Results TimelineVisible improvements by week 6-8, peak results at 10-12 weeks
    Best ForSkin aging, aesthetic rejuvenation, post-surgical healing, tissue repair
    ContraindicationsActive cancer, pregnancy, breastfeeding
    Evidence LevelStrong (individual peptides), Moderate (combination)

    GLOW Vial Composition

    GLOW Vial Composition (50/10/10)

    Add 5mL bacteriostatic water to lyophilized powder

    GHK-Cu

    50mg

    10mg/mL after reconstitution

    Collagen synthesis and skin remodeling

    BPC-157

    10mg

    2mg/mL after reconstitution

    Tissue repair and angiogenesis

    TB-4

    10mg

    2mg/mL after reconstitution

    Cell migration and matrix organization

    Single-Vial Benefits

    Fixed ratios in one vial eliminate multi-vial management. Flexible dosing by adjusting draw volume (0.2-0.5mL). Optimized concentrations for synergistic effect.


    Understanding Each Component

    BPC-157

    Role

    Vascular infrastructure builder and gut-skin axis support

    Mechanism

    →

    Angiogenesis stimulation - Creates new blood vessels for nutrient delivery

    →

    Nitric oxide signaling - Improves circulation and perfusion

    →

    Fibroblast migration - Activates collagen production machinery

    →

    Growth factor modulation - Upregulates VEGF for vascular support

    Key Benefit

    BPC-157 provides systemic healing support that extends beyond local injection sites. Its unique ability to heal intestinal permeability indirectly improves skin health by reducing systemic inflammation.

    Evidence Level

    Strong

    TB-4 (Thymosin Beta-4)

    Role

    Cell migration organizer and inflammation controller

    Mechanism

    →

    Actin-sequestering - Regulates cell structure for organized movement

    →

    Cell migration enhancement - Mobilizes stem cells to repair sites

    →

    Anti-inflammatory modulation - Downregulates NF-κB inflammatory pathway

    →

    Angiogenesis support - Works synergistically with BPC-157

    Key Benefit

    TB-4 excels at soft-tissue repair, particularly for tendons, ligaments, and skin. Its ability to reduce chronic inflammation while promoting cellular migration makes it ideal for both acute and chronic conditions.

    Evidence Level

    Strong

    GHK-Cu (Copper Peptide)

    Role

    Collagen production director and tissue quality optimizer

    Mechanism

    →

    Collagen and elastin upregulation - Increases structural protein synthesis

    →

    MMP modulation - Balances collagen breakdown for tissue remodeling

    →

    Antioxidant activity - Protects regenerating tissue from oxidative damage

    →

    Wound healing acceleration - Improves cosmetic outcomes and scar quality

    Key Benefit

    GHK-Cu specifically targets skin aging and tissue quality. While BPC-157 and TB-4 create infrastructure for healing, GHK-Cu ensures the new tissue is high-quality, elastic, and cosmetically superior.

    Evidence Level

    Strong


    Why Coordination Matters: How GLOW Creates Superior Results

    Most peptide protocols fail not from lack of signals, but from signal interference.

    When you use single peptides or random combinations, repair processes compete:

    • BPC-157 alone builds blood vessels, but without organized cell migration, healing is random
    • TB-4 alone mobilizes cells, but without vascular infrastructure, cells die before reaching target tissue
    • GHK-Cu alone signals collagen production, but without cells or blood supply, nothing happens

    GLOW solves this through simultaneous coordination: all three peptides working together from Day 1, each addressing different bottlenecks in the same healing process.


    All Three Peptides Work Simultaneously

    Every GLOW injection delivers all three signals at once:

    BPC-157: Infrastructure Builder

    • Creates vascular networks (the highways for nutrient delivery)
    • Stabilizes tissue barriers (prevents inflammatory disruption)
    • Establishes safe environment for repair
    • Critical role: Without blood vessels, nothing else can happen

    TB-4: Migration Organizer

    • Directs stem cells and fibroblasts to precise locations
    • Uses BPC-157's vascular roadmap for organized movement
    • Prevents chaotic scarring through controlled migration
    • Critical role: Without organization, you get disorganized scar tissue

    GHK-Cu: Production Director

    • Signals collagen and elastin synthesis genes
    • Optimizes matrix quality throughout the process
    • Works on tissue that BPC-157 vascularized and TB-4 organized
    • Critical role: Without quality control, tissue is structurally weak

    The Synergy Effect

    Think of tissue regeneration like building a city:

    • BPC-157 builds the roads and utilities (infrastructure)
    • TB-4 directs where buildings go (planning and organization)
    • GHK-Cu constructs high-quality buildings (production)

    Without all three working together: roads with no buildings, or buildings without roads, or construction without a plan.

    The synergy creates a cascade effect:

    1. BPC-157 stabilizes damaged tissue and initiates vascular repair signals
    2. TB-4 mobilizes cells to migrate using BPC-157's vascular roadmap in organized patterns
    3. GHK-Cu remodels the new tissue to match original quality
    4. All three promote angiogenesis through different pathways simultaneously
    5. Result: Complete, organized, high-quality tissue regeneration

    Result:

    • Rapid wound closure and reduced scarring
    • Improved collagen quality and elasticity
    • Restored dermal thickness and tone ("glow")
    • Enhanced vascular support for long-term health
    • Durable tissue that resists reinjury
    • Aesthetic improvement (skin, hair, nails)

    This is comprehensive regeneration, not piecemeal repair.


    Why the 50/10/10 Ratio?

    The ratio reflects biological demands, not arbitrary numbers:

    • GHK-Cu 50mg: Collagen production continues throughout entire protocol (highest continuous demand)
    • BPC-157 10mg: Vascular infrastructure establishes early and maintains (front-loaded work)
    • TB-4 10mg: Migration is precision work, not volume-dependent

    This optimized ratio ensures each peptide's concentration matches its biological role in the coordinated cascade.


    Complete GLOW Protocol Benefits

    Primary Benefits

    Improved skin texture and elasticity, Reduced fine lines and wrinkle depth, Accelerated wound healing (surgical, traumatic, or chronic), Enhanced scar appearance and quality, Increased skin hydration and barrier function, Restored skin radiance and even tone, Reduced inflammation and redness, Improved tissue quality (firmer, more resilient).

    Secondary Benefits

    Faster recovery from cosmetic procedures, Reduced post-surgical swelling and bruising, Improved tendon and ligament healing, Enhanced muscle recovery, Better joint comfort and mobility, Gut health support (reduced intestinal permeability), Reduced chronic pain from tissue damage, Hair quality and growth support (via GHK-Cu).

    Long-Term Benefits

    Maintenance of collagen density with aging, Prevention of tissue quality decline, Sustained improvements in skin appearance, Reduced susceptibility to re-injury, Enhanced overall tissue resilience, Better response to physical stressors.


    Timeline: Week-by-Week Progression

    GLOW Protocol Timeline - What to Expect

    All three peptides work simultaneously throughout the protocol, with different biological responses becoming visible over time

    Weeks 1-2

    Foundation Establishment

    All Peptides Active

    • •GHK-Cu: Activating collagen synthesis genes
    • •BPC-157: Building vascular networks
    • •TB-4: Initiating organized cell migration

    Expected Effects

    • ✓Skin hydration improves
    • ✓Tone begins to even
    • ✓Texture starts softening
    • ✓Redness decreases
    Weeks 3-4

    Building Momentum

    All Peptides Active

    • •GHK-Cu: Collagen production accelerating
    • •BPC-157: Vascular support established
    • •TB-4: Cell migration coordinated

    Expected Effects

    • ✓Texture smoothing becomes noticeable
    • ✓Fine lines begin softening
    • ✓Elasticity shows early improvement
    • ✓Inflammation visibly reduced
    Weeks 5-8

    Peak Remodeling

    All Peptides Active

    • •GHK-Cu: Maximum collagen synthesis
    • •BPC-157: Maintaining vascular perfusion
    • •TB-4: Coordinating efficient tissue building

    Expected Effects

    • ✓Fine lines soften significantly
    • ✓Elasticity improves markedly
    • ✓Visible glow returns
    • ✓Skin thickness increases (measurable)
    Weeks 9-12+

    Integration & Maintenance

    All Peptides Active

    • •Pulsed dosing (2-3x weekly)
    • •Collagen maturation and integration
    • •Sustained improvements

    Expected Effects

    • ✓Peak aesthetic results
    • ✓Stable dermal density
    • ✓Sustained firmness
    • ✓Ongoing refinement

    Complete Dosing Protocol

    GLOW Protocol Dosing Phases

    Same mixture, different frequencies to optimize results and prevent receptor downregulation

    Phase 1: Activation

    Weeks 1-4

    Dose

    0.25mL subcutaneous

    Frequency

    Daily

    Per Injection

    GHK-Cu 2.5mg, BPC-157 500mcg, TB-4 500mcg

    Purpose

    Foundation establishment, vascular network building, collagen machinery activation

    Expected Results

    Hydration improves, inflammation reduces, texture begins improving

    Phase 2: Remodeling

    Weeks 5-8

    Dose

    0.25mL subcutaneous

    Frequency

    Daily

    Per Injection

    GHK-Cu 2.5mg, BPC-157 500mcg, TB-4 500mcg

    Purpose

    Maximum collagen synthesis, peak tissue building, organized regeneration

    Expected Results

    Fine lines soften, elasticity improves, visible glow returns

    Phase 3: Maintenance

    Weeks 9+

    Dose

    0.25mL subcutaneous

    Frequency

    2-3× weekly

    Per Injection

    GHK-Cu 2.5mg, BPC-157 500mcg, TB-4 500mcg

    Purpose

    Sustained results, collagen integration, prevent receptor downregulation

    Expected Results

    Peak results maintained, ongoing improvements


    Phase 1: Activation (Weeks 1-4)

    Daily Dose: 0.25 mL subcutaneous (same mixture every day)

    The initial phase establishes the foundation for regeneration by reactivating dormant collagen synthesis machinery and establishing the vascular network necessary for tissue remodeling.

    All three peptides work simultaneously:

    GHK-Cu begins activating collagen synthesis genes (COL1A1, COL3A1) while simultaneously suppressing inflammatory gene expression. The copper acts as a cofactor for lysyl oxidase, enabling proper collagen cross-linking once synthesis begins. Studies show GHK-Cu increases expression of antioxidant enzymes (SOD, catalase) by 40-60%, creating a pro-healing cellular environment.

    BPC-157 stabilizes tissue barriers at the molecular level by upregulating tight junction proteins, preventing inflammatory mediators from disrupting newly formed tissue. Simultaneously, it promotes VEGF expression, establishing the microvascular network necessary for nutrient delivery to healing tissues. This dual action creates stable tissue architecture that can support active regeneration.

    TB-4 mobilizes repair cells to sites of damage through actin sequestration. It sequesters G-actin monomers, allowing rapid assembly into F-actin filaments that drive cell motility. This ensures cellular migration is organized rather than chaotic, preventing excessive fibrosis while promoting functional tissue regeneration. TB-4 also has direct anti-inflammatory effects on vascular endothelium.

    The Synergy: Collagen machinery activates (GHK-Cu) while infrastructure for healing establishes (BPC-157 vascular network + TB-4 organized migration). All three signals present simultaneously, each addressing different bottlenecks.

    Expected Results: Skin hydration improves, tone evens, texture softens, redness decreases


    Phase 2: Remodeling (Weeks 5-8)

    Daily Dose: 0.25 mL subcutaneous (same mixture every day)

    With foundation established in Phase 1, this phase drives maximum collagen synthesis, angiogenesis, and cellular migration—the biological processes that restore youthful tissue architecture.

    All three peptides at peak activity:

    GHK-Cu reaches peak activity in this phase. It upregulates genes for collagen types I and III (structural proteins), activates elastin production (tissue elasticity), stimulates glycosaminoglycan synthesis (tissue hydration), increases expression of antioxidant enzymes, and suppresses genes linked to inflammation and fibrosis. Human studies demonstrate GHK-Cu increases collagen synthesis by 30-70% and reduces wrinkle depth by 35% over 12 weeks.

    BPC-157 continues stabilizing extracellular matrix while promoting vascular growth factor (VEGF) expression. This creates the microvascular network necessary to deliver nutrients and oxygen to sites of active tissue synthesis. Studies show BPC-157 accelerates wound closure by 40-60% through coordinated angiogenic signaling. The established vascular network from Phase 1 now supports intensive collagen deposition.

    TB-4 coordinates cell migration to repair sites through actin-sequestering activity. The organized cellular migration established in Phase 1 now enables efficient tissue remodeling. TB-4 ensures repair cells arrive at damage sites in organized fashion, preventing chaotic healing and excessive scarring. This creates functional tissue that integrates properly with existing structures rather than forming disorganized scar tissue.

    The Synergy: All three compounds work at different stages of the regeneration cascade. BPC-157 and TB-4 ensure the infrastructure for healing (vascular network + organized cell migration), while GHK-Cu drives the production of new structural proteins. Together they create coordinated regeneration across multiple tissue types simultaneously.

    Expected Results: Fine lines soften, elasticity improves, visible glow returns, skin thickness increases (measurable via ultrasound)


    Phase 3: Maintenance (Weeks 9+)

    Maintenance Dose: 0.25 mL subcutaneous, 2-3× weekly (same mixture, less frequent)

    Rather than continuous daily dosing, pulsed administration maintains the regenerative signaling without overwhelming homeostatic mechanisms.

    Strategic Rationale:

    • Prevents receptor downregulation: Continuous peptide exposure causes cellular receptors to become less responsive over time. Pulsed dosing maintains receptor sensitivity and cellular responsiveness to regenerative signals.
    • Allows integration time: The body needs time to organize and cross-link newly synthesized collagen. Constant stimulation can lead to disorganized matrix formation. The 48-72 hour intervals between doses allow proper collagen maturation and integration.
    • Preserves endogenous capacity: The goal is to enhance—not replace—the body's natural repair systems. Pulsed dosing provides periodic reinforcement while maintaining endogenous regenerative capacity. This creates sustainable enhancement rather than dependency.
    • Sustainable long-term: This approach can continue indefinitely without diminishing returns, as cellular machinery remains responsive to periodic signals.

    Duration: Ongoing maintenance, or quarterly 4-week intensive cycles (return to daily dosing for 4 weeks every 3-4 months to amplify results)


    Administration & Reconstitution

    Reconstitution Process:

    1. Add 5mL bacteriostatic water to the lyophilized GLOW vial (50/10/10)
    2. Gently swirl (do not shake) until powder dissolves completely
    3. Final concentrations: 10mg/mL GHK-Cu, 2mg/mL BPC-157, 2mg/mL TB-4

    Injection Technique:

    • Route: Subcutaneous injection
    • Location: Abdomen or thigh, rotate injection sites
    • Timing: Consistent daily timing (morning or evening)
    • Volume: 0.25mL per injection (adjust based on protocol phase)

    Storage:

    • Refrigerate at 2-8°C after reconstitution
    • Stable for 30 days post-reconstitution
    • Protect from light
    • Use sterile technique for all draws

    Supply Planning:

    • Each vial provides 20 doses at 0.25mL
    • 12-week protocol requires: - Weeks 1-8 (daily): 56 doses = 3 vials - Weeks 9-12 (2-3x weekly): 8-12 doses = 1 vial - Total: 3-4 vials for complete 12-week protocol

    Safety & Contraindications

    ⚠️

    Do NOT Use If You Have:

    • Active cancer diagnosis or treatment (due to pro-angiogenic effects of all three peptides)
    • Pregnancy or breastfeeding (insufficient safety data for peptide combinations)
    • Known hypersensitivity to any component peptide (BPC-157, TB-4, or GHK-Cu)

    Consult with a healthcare provider before starting any peptide protocol.

    Side Effects & Tolerability:

    GLOW protocol is generally well-tolerated. Reported side effects are minimal:

    • Mild injection site reactions (redness, slight swelling) - rare
    • Transient warmth or flushing (primarily from GHK-Cu) - uncommon
    • No known systemic side effects at therapeutic doses

    Drug Interactions:

    • No known adverse interactions with medications
    • Can be used alongside standard supplements
    • Synergistic with vitamin C, collagen peptides, NAD+

    Monitoring Recommendations:

    • Track skin quality changes via photos (weekly)
    • Monitor for any adverse reactions
    • Adjust dosing based on individual response
    • Annual bloodwork for long-term maintenance protocols

    Cost Analysis

    12-Week GLOW Protocol Cost Breakdown:

    Compounding Pharmacy (Pharmaceutical Grade):

    • 4 vials @ $250-350/vial = $1,000-1,400
    • Bacteriostatic water (20mL) = $15-25
    • Syringes and supplies = $30-50
    • Total: $1,045-1,475
    • Cost per day (weeks 1-8): ~$18.75
    • Cost per injection: ~$18.75

    Research Suppliers (Verified Quality):

    • 4 vials @ $150-220/vial = $600-880
    • Bacteriostatic water (20mL) = $10-15
    • Syringes and supplies = $30-50
    • Total: $640-945
    • Cost per day (weeks 1-8): ~$11.50
    • Cost per injection: ~$11.50

    Supporting Supplements (Optional but Recommended):

    • Vitamin C: $10-15/month
    • Collagen peptides: $25-40/month
    • Total support: $35-55/month

    Cost Comparison:

    For context, professional cosmetic procedures offering similar collagen and skin quality improvements:

    • Laser resurfacing: $1,500-3,000 per treatment
    • Microneedling with PRP: $500-800 per session (4-6 sessions recommended)
    • Injectable fillers: $600-1,200 per syringe (temporary, 6-12 months)

    GLOW protocol offers comprehensive tissue regeneration at comparable or lower cost with sustainable results.


    Frequently Asked Questions

    What is the GLOW protocol?

    The GLOW protocol combines three peptides (BPC-157, TB-4, GHK-Cu) in a single vial for coordinated tissue regeneration. Standard dosing: 0.25mL per injection, reconstituted with 5mL bacteriostatic water, injected subcutaneously for 8-12 weeks. Results visible by weeks 6-8.

    How much does the GLOW protocol cost?

    GLOW protocol costs $640-$1,475 for 12 weeks depending on source:

    • Compounding pharmacy: $1,045-$1,475 (pharmaceutical grade)
    • Research suppliers: $640-$945 (verified quality)
    • Supporting supplements: $35-55/month (optional)

    Cost per day: approximately $11-19 for standard protocol.

    How long before GLOW protocol shows results?

    GLOW protocol results timeline:

    • Weeks 1-2: Reduced inflammation, improved hydration
    • Weeks 3-4: Skin texture smoothing begins
    • Weeks 6-8: Visible improvements (fine lines soften, elasticity improves)
    • Weeks 10-12: Peak aesthetic and functional results

    Most users notice changes by week 4, with undeniable results by weeks 6-8.

    What peptides are in the GLOW protocol?

    GLOW protocol contains three peptides in a single 50/10/10 vial:

    • GHK-Cu: 50mg (collagen synthesis and tissue remodeling)
    • BPC-157: 10mg (vascular infrastructure and healing initiation)
    • TB-4: 10mg (coordinated cell migration and anti-inflammatory)

    Reconstitute with 5mL bacteriostatic water for precise daily dosing.

    Can I use GLOW protocol with GLP-1 medications?

    Yes, GLOW protocol can be used alongside GLP-1 medications (semaglutide, tirzepatide). The peptides work through different mechanisms and do not interfere. GLOW may help preserve skin quality during weight loss by supporting collagen synthesis. Monitor for any individual sensitivities and consult your healthcare provider.

    Is the GLOW protocol safe long-term?

    Yes, based on available data. Component peptides show favorable safety profiles for 2-5 years of maintenance use without adverse effects. Conservative approach: run 12-week protocols with 4-8 week breaks, or use low-dose maintenance (0.25mL 2-3x/week) with annual bloodwork monitoring. Contraindicated in active cancer and pregnancy.

    Can I make my own GLOW protocol from separate vials?

    Yes, but single-vial GLOW offers advantages: optimized 50/10/10 ratio, no mixing errors, simplified dosing. To DIY: purchase GHK-Cu 50mg, BPC-157 10mg, TB-4 10mg separately, reconstitute each appropriately, inject all three daily. Cost similar but requires three daily injections instead of one.

    GLOW protocol vs Wolverine stack - which is better?

    GLOW protocol prioritizes skin rejuvenation and cosmetic outcomes with GHK-Cu emphasis. Wolverine stack focuses purely on injury recovery with higher BPC-157/TB-4 ratios. Choose GLOW for: aging skin, post-surgical healing, aesthetic goals. Choose Wolverine for: sports injuries, tendon repair, athletic recovery. Both work; goals determine best fit.

    What's the difference between GLOW and KLOW protocols?

    GLOW: GHK-Cu 50mg + BPC-157 10mg + TB-4 10mg (skin aging, general tissue repair)
    KLOW: Adds KPV 10mg to GLOW blend (inflamed/reactive skin, rosacea, post-procedure recovery)

    KLOW includes KPV for additional anti-inflammatory control. Use KLOW if skin is reactive, inflamed, or prone to redness. Use GLOW for standard anti-aging and tissue repair.

    How do I store reconstituted GLOW vials?

    Refrigerate at 2-8°C after reconstitution. Stable for 30 days. Protect from light and heat. Use sterile technique for all draws. Do not freeze. If traveling, use insulated cooler with ice packs.

    Can I use GLOW protocol for post-surgical healing?

    Yes, GLOW protocol is excellent for post-surgical healing. All three peptides support wound closure, scar quality, and tissue regeneration. Start 1-2 weeks post-surgery (after initial wound closure). Consult your surgeon before beginning. Expected benefits: faster healing, reduced scarring, better cosmetic outcomes.

    What injection sites work best for GLOW protocol?

    Subcutaneous injection into abdomen or thigh works best. Rotate injection sites to prevent irritation. Abdomen preferred for systemic effects. Near-injury injection (if localized concern) also effective but not required. Avoid areas with active inflammation or infection.

    Do I need to cycle off GLOW protocol?

    Not required for maintenance dosing (2-3x weekly). For intensive protocols (daily dosing), options:

    1. Run 12 weeks, take 4-8 week break, repeat
    2. Transition to maintenance dosing (2-3x weekly) indefinitely
    3. Quarterly intensive cycles (4 weeks daily every 3-4 months)

    Pulsed maintenance dosing prevents receptor downregulation and can continue long-term.

    Can I increase GLOW dosing for faster results?

    Standard dosing (0.25mL) is optimized for most users. Increasing to 0.3-0.5mL may accelerate early results but also increases cost and doesn't necessarily improve final outcomes. Start with 0.25mL for 4 weeks, assess response, then adjust if needed. Higher doses don't always equal better results.

    What support supplements enhance GLOW protocol results?

    Recommended supplements:

    • Vitamin C: 500-1000mg daily (collagen synthesis cofactor)
    • Collagen peptides: 10-20g daily (provides building blocks)
    • Protein: 0.8-1.0g per lb bodyweight (substrate for tissue building)
    • Hydration: 2-3L daily (tissue volume and delivery)

    Optional adjuncts: Red light therapy (630-670nm), microneedling (every 3-4 weeks during Phase 2), topical GHK-Cu on non-injection days.


    Conclusion

    The GLOW protocol represents a paradigm shift in peptide therapy: coordinated signals that create organized, high-quality tissue regeneration instead of chaotic repair. By delivering all three peptides simultaneously—each addressing different bottlenecks in the healing process—GLOW enables the body to rebuild tissue the way it was meant to: with vascular support, organized migration, and optimized collagen quality.

    Whether your goal is anti-aging, post-surgical healing, or comprehensive tissue repair, GLOW provides the biochemical foundation for sustainable results.

    Ready to start? Use the protocol information above to plan your implementation, or consult with a healthcare provider familiar with peptide therapy for personalized guidance.


    Related GLOW Resources

    Aesthetic Applications

    Peptides for Skin Rejuvenation: GLOW Protocol Benefits & Science — Focused guide on GLOW peptides for skin health, aesthetic applications, and cosmetic benefits with subcutaneous administration techniques for anti-aging and skin rejuvenation.

    Injury Recovery Tier System

    Tier II: GLOW/KLOW Stack — Intermediate injury recovery protocol using NAD+ + GHK-Cu + KPV for weeks 4-10 of tissue rebuilding (different formulation from this pre-mixed GLOW vial).

    Key Distinction: This complete guide covers the pre-mixed GLOW vial (GHK-Cu + BPC-157 + TB-4) for coordinated tissue regeneration, while the Tier II article focuses on individually-dosed peptides with NAD+ for injury recovery.